Oncology
A topic in the Science corpus, drawn from 9,301 papers.
Trusted voices in Oncology
Ordered by the trust Oncology's own network concentrates on each researcher, most first.
- R. Weinberg — trusted by 179 researchers here
- D. Pardoll — trusted by 112 researchers here
- J. P. Thiery — trusted by 93 researchers here
- M. Karin — trusted by 108 researchers here
- Zena Werb — trusted by 86 researchers here
- A. Mantovani — trusted by 71 researchers here
- F. Balkwill — trusted by 69 researchers here
- J. Pollard — trusted by 69 researchers here
- Karen H. Vousden — trusted by 79 researchers here
- J. Massagué — trusted by 64 researchers here
- Hans Clevers — trusted by 60 researchers here
- Lisa M. Coussens — trusted by 54 researchers here
Most-cited papers in Oncology
Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries (2021, Ca) — 96,839 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2018, Ca) — 74,806 citations
- Global cancer statistics (2011, Ca) — 65,229 citations
- Hallmarks of cancer: the next generation. (2011, Cell) — 63,567 citations
- Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey (2004, Annals of Surgery) — 30,610 citations
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2024, Ca) — 29,832 citations
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 (2015, International Journal of Cancer) — 27,202 citations
- Clinical Characteristics of Coronavirus Disease 2019 in China (2020, Journal of Emergency Medicine) — 24,808 citations
- Global cancer statistics, 2012 (2015, Ca) — 24,749 citations
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (2020, The Lancet) — 23,319 citations
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010, International Journal of Cancer) — 21,956 citations
- Global Cancer Statistics, 2002 (2005, Ca) — 18,664 citations
- Cancer statistics, 2020 (2020, Ca) — 18,458 citations
- Cancer statistics, 2019 (2019, Ca) — 18,371 citations
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. (2006, Cytotherapy) — 17,261 citations
- Cancer statistics, 2018 (2018, Ca) — 15,804 citations
- Cancer statistics, 2023 (2023, Ca) — 15,183 citations
- Cancer statistics, 2022 (2022, Ca) — 15,111 citations
- Cancer statistics in China, 2015 (2016, Ca) — 14,563 citations
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (2010, New England Journal of Medicine) — 14,544 citations
- Cancer statistics, 2016 (2016, Ca) — 14,496 citations
- Cancer Statistics, 2021 (2021, Ca) — 14,456 citations
- Cancer statistics, 2017 (2017, Ca) — 14,452 citations
- Cancer Statistics, 2010 (2010, Ca) — 13,209 citations
- The blockade of immune checkpoints in cancer immunotherapy (2012, Nature Reviews. Cancer) — 12,881 citations
- Dermatologist-level classification of skin cancer with deep neural networks (2017) — 12,830 citations
- New guidelines to evaluate the response to treatment in solid tumors (2000, Journal of the National Cancer Institute) — 12,595 citations
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (2012, New England Journal of Medicine) — 11,924 citations
- Cancer statistics, 2013 (2013, Ca) — 11,779 citations
- Cancer-related inflammation (2008, Nature) — 11,101 citations
- Cancer statistics, 2014 (2014, Ca) — 10,985 citations
- Cancer statistics, 2012 (2012, Ca) — 10,740 citations
- Prospective identification of tumorigenic breast cancer cells (2003, Proceedings of the National Academy of Sciences of the United States of America) — 10,686 citations
- Cancer Statistics, 2008 (2008, Ca) — 10,473 citations
- Immunity, Inflammation, and Cancer (2010, Cell) — 10,296 citations
- Cancer statistics, 2024 (2024, Ca) — 10,166 citations
- Cancer statistics, 2015 (2015, Ca) — 10,157 citations
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (2004, New England Journal of Medicine) — 9,988 citations
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (2004, Science) — 9,841 citations
- Epithelial-mesenchymal transitions in development and disease. (2009, Cell) — 9,583 citations
- Stem cells, cancer, and cancer stem cells (2001, Nature) — 9,275 citations
- The epithelial-mesenchymal transition generates cells with properties of stem cells. (2008, Cell) — 8,764 citations
- Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. (2016, New England Journal of Medicine) — 8,730 citations
- Prevalence of Childhood and Adult Obesity in the United States, 2011–2012 (2014, Journal of the American Medical Association (JAMA)) — 8,689 citations
- Pancreatic cancer. (2013, Clinical Chemistry) — 8,552 citations
- Nivolumab versus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer (2015, New England Journal of Medicine) — 8,405 citations
- Inferring tumour purity and stromal and immune cell admixture from expression data (2013, Nature Communications) — 7,904 citations
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies (2001, Tissue engineering) — 7,901 citations
- Comprehensive molecular portraits of human breast tumours (2013) — 7,883 citations
- Inflammation and cancer (2002, Nature) — 7,865 citations
Most active researchers
By papers in this topic: a volume measure, not trust.
- A. Jemal — 84 papers
- J. Wolchok — 62 papers
- Hans Clevers — 50 papers
- R. Siegel — 49 papers
- F. Bray — 46 papers
- S. Rosenberg — 46 papers
- Antoni Ribas — 43 papers
- C. Robert — 38 papers
- R. Weinberg — 38 papers
- James P. Allison — 36 papers
- J. Ferlay — 36 papers
- Jie Yang — 36 papers